Lymph node metastasis (LNM) is a crucial risk factor influencing an unfavorable prognosis in specific cancers. Fundamental research illuminates our understanding of tumor behavior and identifies valuable therapeutic targets. Nevertheless, the exploration of fundamental theories and the validation of clinical therapies hinge on preclinical experiments. Preclinical models, in this context, serve as the conduit connecting fundamental theories to clinical outcomes. In vivo models established in animals offer a valuable platform for comprehensively observing interactions between tumor cells and organisms. Using various experimental animals, including mice, diverse methods, such as carcinogen-induced tumorigenesis, tumor cell line or human tumor transplantation, genetic engineering, and humanization, have been used effectively to construct numerous models for tumor LNM. Carcinogen-induced models simulate the entire process of tumorigenesis and metastasis. Transplantation models, using human tumor cell lines or patient-derived tumors, offer a research platform closely mirroring the histology and clinical behavior of human tumors. Genetically engineered models have been used to delve into the mechanisms of primary tumorigenesis within an intact microenvironment. Humanized models are used to overcome barriers between human and murine immune systems. Beyond mouse models, various other animal models have unique advantages and limitations, all contributing to exploring LNM. This review summarizes existing in vitro and animal preclinical models, identifies current bottlenecks in preclinical research, and offers an outlook on forthcoming preclinical models.
Animals ; Humans ; Mice ; Lymphatic Metastasis/pathology* ; Disease Models, Animal ; Cell Line, Tumor

Objective:To establish an atomic fluorescence detection method for bismuth and bismuth telluride (Bi 2Te 3) in the air of workplaces. Methods:In March 2024, the acetate-fiber filter material was digested by ultrawave and detected by atomic fluorescence spectrometry to obtain the content of bismuth and Bi 2Te 3 in the air of the workplace. Results:The correlation coefficients of standard curve were above 0.9990, The detection limit of bismuth was 0.02 μg/L, the minimum detection concentration was 0.02 μg/m 3, the minimum quantitation concentration was 0.06 μg/m 3, the minimum detection concentration and the minimum quantitation concentration of Bi 2Te 3 was 0.03 μg/m 3 and 0.09 μg/m 3 respectively. The digestion efficiency ranged from 98.6% to 102 %, the RSDs of intra-batch and inter-batch were below 1.3% and 4.0% respectively. The samples were stable within 7 days, and interference elements of 1.0 mg/L (Ag, Al, As, B, Ba, Be, Cd, Co, Cr, Cs, Cu, Fe, Ga, Li, Mg, Mn, Mo, Ni, Pb, Rb, Sb, Se, Sn, Sr, Ti, Tl, V, Zn, Zr) do not affect the detection of bismuth. Conclusion:This method is simple, fast, accurate, and highly sensitive, and can meet the requirements of the determination of bismuth and bismuth telluride in the air of working place.

Cancer-induced bone pain(CIBP)causes substantial suffering for cancer patients and also diminishes their quality of life and self-esteem.The mechanisms underlying CIBP are complex and evolve progressively with cancer advancement.Current treatment options show limited efficacy and are often accompanied by adverse effects.Traditional Chinese medicine demonstrates potential advantages in managing CIBP;however,the mechanisms of action remain poorly understood and require further investigation.The development of a standardized,stable,and reproducible animal model is crucial to advancing research on disease pathogenesis and verifying the effectiveness of therapeutic interventions.This review considers recent method for modeling CIBP in animals and summarizes the application of these models in studies of traditional Chinese medicine mechanisms,with the aim of guiding future research directions in CIBP.

Objective:To establish a rapid method for determination of iodine in water by sodium persulfate oxidation inductively coupled plasma mass spectrometry (ICP-MS).Methods:A 100 μl of 30% sodium persulfate solution was added to 10 ml of water sample, followed by reaction at room temperature for 30 min. A 50 μg/L mixed solution containing indium and 8 other elements was used as the internal standard solution. The flow ratio of the internal standard solution to the test solution was 1∶7. The iodine in water was determined by ICP-MS. The linear range, detection limit, accuracy, precision, and anti-interference ability of the method were evaluated.Results:Iodine in water could be determined and had a good linear relationship within the range of 0 - 100 μg/L, with a correlation coefficient ( r) of ≥0.999 9. The detection limits of potassium iodate and potassium iodide were 0.07 and 0.08 μg/L, respectively, and the quantitation limits were 0.24 and 0.26 μg/L, respectively. The low, medium, and high concentration spiked recovery rates of six substrate water samples (source water, treated water, end-use water, packaged drinking water, packaged mineral water, and natural mineral water) ranged from 94.0% to 104.0%, with a relative standard deviations ( RSD) ranged from 0.5% to 2.8%. Interference test confirmed that 29 elements (at 1.00 mg/L) did not affect the determination of iodine at 6.00 μg/L. The determination results of the standard substance (GBW09114K) for iodine content in water were all within the standard range (56.0 - 68.0 μg/L), with an RSD of 0.6%. Conclusions:A method for rapid determination of iodine in water by the sodium persulfate oxidation ICP-MS method is successfully established. This method is easy to operate, has high sensitivity and good accuracy, and is suitable for batch analysis of iodine in drinking water and mineral water.

Background and Aims:Centrally located breast cancer(CLBC),due to its proximity to the nipple-areolar complex,has long been treated primarily with mastectomy,while the oncologic safety of breast-conserving surgery(BCS)remains controversial.This study,based on a large-scale database combined with a real-world cohort,compared the survival outcomes of BCS and mastectomy to evaluate the feasibility and oncologic safety of BCS in CLBC patients.Methods:Data of 10 325 female CLBC patients diagnosed between 2010 and 2015 were extracted from the SEER database,including 5 601 patients who underwent BCS and 4 724 who underwent mastectomy.Propensity score matching(PSM)yielded 1 951 matched pairs,and disease-specific survival(DSS)and overall survival(OS)were compared between groups.Cox regression analyses were performed to identify prognostic factors,and subgroup analyses were conducted.Additionally,an independent validation cohort from Xiangya Hospital,Central South University(2015-2016)included 221 BCS and 636 mastectomy patients,with OS and progression-free survival(PFS)assessed.Results:After PSM,baseline characteristics between groups were well balanced.Kaplan-Meier analysis demonstrated no significant differences in DSS or OS between BCS and mastectomy,and 5-,7-,and 10-year OS rates were comparable(all P＞0.05).Subgroup analyses revealed equivalent outcomes for BCS and mastectomy in patients with T1/T2 disease,different HER2 statuses,and those receiving chemotherapy,while in patients receiving radiotherapy,BCS showed significantly better DSS and OS than mastectomy(both P＜0.05).Multivariate Cox regression identified T,N,and M stage,histologic grade,molecular subtype,ER/PR status,and chemotherapy as independent prognostic factors(all P＜0.05),whereas surgical type was not(P＞0.05).The validation cohort confirmed the SEER findings,with no significant differences in OS or PFS between the two groups(both P＞0.05).Conclusions:BCS provides DSS and OS comparable to mastectomy in CLBC patients and may confer additional survival benefits when combined with radiotherapy.These findings suggest that CLBC should not be considered a contraindication to BCS,supporting BCS as a feasible and safe surgical strategy that offers valuable evidence for individualized clinical decision-making and may help improve patients' quality of life.

Objective:To establish an atomic fluorescence detection method for bismuth and bismuth telluride (Bi 2Te 3) in the air of workplaces. Methods:In March 2024, the acetate-fiber filter material was digested by ultrawave and detected by atomic fluorescence spectrometry to obtain the content of bismuth and Bi 2Te 3 in the air of the workplace. Results:The correlation coefficients of standard curve were above 0.9990, The detection limit of bismuth was 0.02 μg/L, the minimum detection concentration was 0.02 μg/m 3, the minimum quantitation concentration was 0.06 μg/m 3, the minimum detection concentration and the minimum quantitation concentration of Bi 2Te 3 was 0.03 μg/m 3 and 0.09 μg/m 3 respectively. The digestion efficiency ranged from 98.6% to 102 %, the RSDs of intra-batch and inter-batch were below 1.3% and 4.0% respectively. The samples were stable within 7 days, and interference elements of 1.0 mg/L (Ag, Al, As, B, Ba, Be, Cd, Co, Cr, Cs, Cu, Fe, Ga, Li, Mg, Mn, Mo, Ni, Pb, Rb, Sb, Se, Sn, Sr, Ti, Tl, V, Zn, Zr) do not affect the detection of bismuth. Conclusion:This method is simple, fast, accurate, and highly sensitive, and can meet the requirements of the determination of bismuth and bismuth telluride in the air of working place.

Background and Aims:Centrally located breast cancer(CLBC),due to its proximity to the nipple-areolar complex,has long been treated primarily with mastectomy,while the oncologic safety of breast-conserving surgery(BCS)remains controversial.This study,based on a large-scale database combined with a real-world cohort,compared the survival outcomes of BCS and mastectomy to evaluate the feasibility and oncologic safety of BCS in CLBC patients.Methods:Data of 10 325 female CLBC patients diagnosed between 2010 and 2015 were extracted from the SEER database,including 5 601 patients who underwent BCS and 4 724 who underwent mastectomy.Propensity score matching(PSM)yielded 1 951 matched pairs,and disease-specific survival(DSS)and overall survival(OS)were compared between groups.Cox regression analyses were performed to identify prognostic factors,and subgroup analyses were conducted.Additionally,an independent validation cohort from Xiangya Hospital,Central South University(2015-2016)included 221 BCS and 636 mastectomy patients,with OS and progression-free survival(PFS)assessed.Results:After PSM,baseline characteristics between groups were well balanced.Kaplan-Meier analysis demonstrated no significant differences in DSS or OS between BCS and mastectomy,and 5-,7-,and 10-year OS rates were comparable(all P＞0.05).Subgroup analyses revealed equivalent outcomes for BCS and mastectomy in patients with T1/T2 disease,different HER2 statuses,and those receiving chemotherapy,while in patients receiving radiotherapy,BCS showed significantly better DSS and OS than mastectomy(both P＜0.05).Multivariate Cox regression identified T,N,and M stage,histologic grade,molecular subtype,ER/PR status,and chemotherapy as independent prognostic factors(all P＜0.05),whereas surgical type was not(P＞0.05).The validation cohort confirmed the SEER findings,with no significant differences in OS or PFS between the two groups(both P＞0.05).Conclusions:BCS provides DSS and OS comparable to mastectomy in CLBC patients and may confer additional survival benefits when combined with radiotherapy.These findings suggest that CLBC should not be considered a contraindication to BCS,supporting BCS as a feasible and safe surgical strategy that offers valuable evidence for individualized clinical decision-making and may help improve patients' quality of life.

Objective:To establish a rapid method for determination of iodine in water by sodium persulfate oxidation inductively coupled plasma mass spectrometry (ICP-MS).Methods:A 100 μl of 30% sodium persulfate solution was added to 10 ml of water sample, followed by reaction at room temperature for 30 min. A 50 μg/L mixed solution containing indium and 8 other elements was used as the internal standard solution. The flow ratio of the internal standard solution to the test solution was 1∶7. The iodine in water was determined by ICP-MS. The linear range, detection limit, accuracy, precision, and anti-interference ability of the method were evaluated.Results:Iodine in water could be determined and had a good linear relationship within the range of 0 - 100 μg/L, with a correlation coefficient ( r) of ≥0.999 9. The detection limits of potassium iodate and potassium iodide were 0.07 and 0.08 μg/L, respectively, and the quantitation limits were 0.24 and 0.26 μg/L, respectively. The low, medium, and high concentration spiked recovery rates of six substrate water samples (source water, treated water, end-use water, packaged drinking water, packaged mineral water, and natural mineral water) ranged from 94.0% to 104.0%, with a relative standard deviations ( RSD) ranged from 0.5% to 2.8%. Interference test confirmed that 29 elements (at 1.00 mg/L) did not affect the determination of iodine at 6.00 μg/L. The determination results of the standard substance (GBW09114K) for iodine content in water were all within the standard range (56.0 - 68.0 μg/L), with an RSD of 0.6%. Conclusions:A method for rapid determination of iodine in water by the sodium persulfate oxidation ICP-MS method is successfully established. This method is easy to operate, has high sensitivity and good accuracy, and is suitable for batch analysis of iodine in drinking water and mineral water.

Cancer-induced bone pain(CIBP)causes substantial suffering for cancer patients and also diminishes their quality of life and self-esteem.The mechanisms underlying CIBP are complex and evolve progressively with cancer advancement.Current treatment options show limited efficacy and are often accompanied by adverse effects.Traditional Chinese medicine demonstrates potential advantages in managing CIBP;however,the mechanisms of action remain poorly understood and require further investigation.The development of a standardized,stable,and reproducible animal model is crucial to advancing research on disease pathogenesis and verifying the effectiveness of therapeutic interventions.This review considers recent method for modeling CIBP in animals and summarizes the application of these models in studies of traditional Chinese medicine mechanisms,with the aim of guiding future research directions in CIBP.

OBJECTIVE To investigate the current situation of clinical trial institutions in Chongqing after the recording system of clinical trial institutions, and to put forward suggestions. METHODS A total of 34 clinical trial institutions in Chongqing were selected as the research objects. The research contents mainly included the basic situation of the institutions, staffing, hardware and software construction, project operation and work difficulties, etc. Combined with the research results, suggestions were put forward for the difficulties of the new and old institutions in the operation of clinical trial institutions. RESULTS A total of 29 questionnaires were collected and 29 were valid. The release of clinical trial resources in Chongqing were not sufficient and uniform, there were problems such as insufficient incentive policies, lack of information platform construction, and the number and professional degrees of practitioners need to be improved. The new institutions had certain advantages in project load, office space and willingness to undertake, but it was restricted by principle investigator qualification, project experience and institutional reputation. CONCLUSION It is suggested to clarify the incentive mechanism, enhance the enthusiasm of clinical trials and establish a standardized training mechanism for clinical trial professionals. Make full use of the information platform to improve the efficiency of clinical trials, build a regional information platform to share information and resources, and accelerate the development of regional clinical trials.